150 related articles for article (PubMed ID: 33725656)
21. Inhibition of Niemann-Pick C1-like protein 1 by ezetimibe reduces uptake of deuterium-labeled vitamin D in mice.
Kiourtzidis M; Kühn J; Schutkowski A; Baur AC; Hirche F; Stangl GI
J Steroid Biochem Mol Biol; 2020 Mar; 197():105504. PubMed ID: 31682937
[TBL] [Abstract][Full Text] [Related]
22. Bean peptides have higher in silico binding affinities than ezetimibe for the N-terminal domain of cholesterol receptor Niemann-Pick C1 Like-1.
Real Hernandez LM; Gonzalez de Mejia E
Peptides; 2017 Apr; 90():83-89. PubMed ID: 28259659
[TBL] [Abstract][Full Text] [Related]
23. Virtual screening for cholesterol absorption inhibitors.
Sun L; Qian H; Huang W
Med Chem; 2014; 11(1):2-12. PubMed ID: 24773346
[TBL] [Abstract][Full Text] [Related]
24. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor.
Sainz B; Barretto N; Martin DN; Hiraga N; Imamura M; Hussain S; Marsh KA; Yu X; Chayama K; Alrefai WA; Uprichard SL
Nat Med; 2012 Jan; 18(2):281-5. PubMed ID: 22231557
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects.
Zambrano T; Saavedra N; Lanas F; Caamaño J; Salazar LA
Mol Diagn Ther; 2015 Feb; 19(1):45-52. PubMed ID: 25589339
[TBL] [Abstract][Full Text] [Related]
26. Structure-activity relationship studies of Niemann-Pick type C1-like 1 (NPC1L1) ligands identified by screening assay monitoring pharmacological chaperone effect.
Karaki F; Ohgane K; Dodo K; Hashimoto Y
Bioorg Med Chem; 2013 Sep; 21(17):5297-309. PubMed ID: 23830695
[TBL] [Abstract][Full Text] [Related]
27. Intestinal CREBH overexpression prevents high-cholesterol diet-induced hypercholesterolemia by reducing
Kikuchi T; Orihara K; Oikawa F; Han SI; Kuba M; Okuda K; Satoh A; Osaki Y; Takeuchi Y; Aita Y; Matsuzaka T; Iwasaki H; Yatoh S; Sekiya M; Yahagi N; Suzuki H; Sone H; Nakagawa Y; Yamada N; Shimano H
Mol Metab; 2016 Nov; 5(11):1092-1102. PubMed ID: 27818935
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the NPC1L1 gene and proteome from an exceptional responder to ezetimibe.
Schweitzer M; Makhoul S; Paliouras M; Beitel LK; Gottlieb B; Trifiro M; Chowdhury SF; Zaman NM; Wang E; Davis H; Chalifour LE
Atherosclerosis; 2016 Mar; 246():78-86. PubMed ID: 26761771
[TBL] [Abstract][Full Text] [Related]
29. Orlistat limits cholesterol intestinal absorption by Niemann-pick C1-like 1 (NPC1L1) inhibition.
Alqahtani S; Qosa H; Primeaux B; Kaddoumi A
Eur J Pharmacol; 2015 Sep; 762():263-9. PubMed ID: 26048312
[TBL] [Abstract][Full Text] [Related]
30. Hypocholesterolemic Activity of Curcumin Is Mediated by Down-regulating the Expression of Niemann-Pick C1-like 1 in Hamsters.
Feng D; Zou J; Zhang S; Li X; Lu M
J Agric Food Chem; 2017 Jan; 65(2):276-280. PubMed ID: 28000447
[TBL] [Abstract][Full Text] [Related]
31. Pravastatin Modulate Niemann-Pick C1-Like 1 and ATP-Binding Cassette G5 and G8 to Influence Intestinal Cholesterol Absorption.
Kawase A; Hata S; Takagi M; Iwaki M
J Pharm Pharm Sci; 2015; 18(5):765-72. PubMed ID: 26670369
[TBL] [Abstract][Full Text] [Related]
32. Cholesterol homeostasis by the intestine: lessons from Niemann-Pick C1 Like 1 [NPC1L1).
Davis HR; Basso F; Hoos LM; Tetzloff G; Lally SM; Altmann SW
Atheroscler Suppl; 2008 Sep; 9(2):77-81. PubMed ID: 18585981
[TBL] [Abstract][Full Text] [Related]
33. Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter.
Davis HR; Altmann SW
Biochim Biophys Acta; 2009 Jul; 1791(7):679-83. PubMed ID: 19272334
[TBL] [Abstract][Full Text] [Related]
34. NPC1L1: evolution from pharmacological target to physiological sterol transporter.
Huff MW; Pollex RL; Hegele RA
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2433-8. PubMed ID: 16973966
[TBL] [Abstract][Full Text] [Related]
35. Discovery, synthesis and evaluation of novel cholesterol absorption inhibitors.
Zhu X; Ji J; Huang D; Zhu Y; Tang C; Yang X; Qian H; Huang W
Chem Biol Drug Des; 2012 Sep; 80(3):426-33. PubMed ID: 22642541
[TBL] [Abstract][Full Text] [Related]
36. Transporters as drug targets: discovery and development of NPC1L1 inhibitors.
Betters JL; Yu L
Clin Pharmacol Ther; 2010 Jan; 87(1):117-21. PubMed ID: 19907422
[TBL] [Abstract][Full Text] [Related]
37. Spiroimidazolidinone NPC1L1 inhibitors. Part 2: structure-activity studies and in vivo efficacy.
Howell KL; DeVita RJ; Garcia-Calvo M; Meurer RD; Lisnock J; Bull HG; McMasters DR; McCann ME; Mills SG
Bioorg Med Chem Lett; 2010 Dec; 20(23):6929-32. PubMed ID: 21030254
[TBL] [Abstract][Full Text] [Related]
38. Ezetimibe, a selective inhibitor of the transport of cholesterol.
Miura S; Saku K
Intern Med; 2008; 47(13):1165-70. PubMed ID: 18591835
[TBL] [Abstract][Full Text] [Related]
39. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption.
Altmann SW; Davis HR; Zhu LJ; Yao X; Hoos LM; Tetzloff G; Iyer SP; Maguire M; Golovko A; Zeng M; Wang L; Murgolo N; Graziano MP
Science; 2004 Feb; 303(5661):1201-4. PubMed ID: 14976318
[TBL] [Abstract][Full Text] [Related]
40. Pharaceutical chemical characterization of ezetimibe.
Blanka SS; Gabor O; Hajnal K
Acta Pharm Hung; 2016; 86(4):133-139. PubMed ID: 29870599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
